Biolexis Therapeutics CSO invited to Chair Cancer Immunology & Immunotherapy session and present MolecuLern technology at 14th Annual World Cancer Congress – WCC 11: Cancer Immunology & Immunotherapy on July 22-24, 2023, at Barcelona, Spain.
April 10-11, 2023 Biolexis Therapeutics CSO invited to present company MolecuLern™ technology at 2023 Annual San Antonio Drug Discovery Symposium held at Greehey Children’s Cancer Research Institute of University of Texas Health San Antonio....
April 8-13, 2023 Biolexis management participated and presented pre-clinical data on CDK9 inhibitor at the AACR (American Association of Cancer Research) Annual Meeting on April 8-13, 2022, Ernest N. Morial Convention Center New Orleans, Louisiana. B137 / 13 -...
February 22-23, 2023 Biolexis Therapeutics Business Development team participated 2nd Next Generation Kinase Inhibitors Summit was held on February 22-23, 2023, in Boston.